Skip to main content
Premium Trial:

Request an Annual Quote

BYU Taps Tute Genomics' Platform to Support Alzheimer's Research

Premium

NEW YORK (GenomeWeb) – Brigham Young University is using Tute Genomics' genome annotation and interpretation platform to analyze next generation sequencing data from an Alzheimer's disease research project.

BYU will use the platform, Tute said, to analyze genetic data from more than 1000 exomes and genomes to identify new genetic variants associated with Alzheimers. Specifically, a research team led by John Kauwe, an assistant professor in BYU's biology department, is using the platform to identify potential therapeutic targets. "We have been extremely impressed with the Tute platform thus far, and we already have a number of research findings we are evaluating," Kauwe said in a statement.

The BYU project is part of a larger collaborative effort called the Alzheimer's Genetic Analysis Group. Other participants in the project include University College London, Washington University School of Medicine, and the National Institutes of Health.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.